On the other hand, pharmacological inhibition of ADH enzyme has been shown to diminish or prevent ethanol-induced undesirable effects such as lactacidemia and hypoglycemia [39], indicating the therapeutic potential of this crucial ethanol oxidation enzyme. The gene discussed is AVP; the disease is Hypoglycemia.